Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Free Report) and Connect Biopharma (NASDAQ:CNTB – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership. Institutional and Insider Ownership 58.7% of Connect […]

Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) and Zymeworks (NASDAQ:ZYME – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends. Volatility & Risk Arrowhead Pharmaceuticals has a beta of […]

Propanc Biopharma (NASDAQ:PPCB – Get Free Report) and Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation. Volatility & Risk Propanc Biopharma has a beta […]

Connect Biopharma (NASDAQ:CNTB – Get Free Report) and NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership. Risk and Volatility Connect Biopharma has a beta […]

Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) and Purple Biotech (NASDAQ:PPBT – Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation. Valuation & Earnings This table compares Ionis Pharmaceuticals […]